life sciences

Life Sciences Arbitration

CRA’s life sciences arbitration support is grounded in a comprehensive, insiders’ understanding of pharmaceutical, biotechnology, medical device, and diagnostic markets. For more than 25 years, we have consulted directly with major life science companies, law firms, and regulatory agencies around the globe. This deep industry knowledge is complemented by our extensive experience in complex litigation. CRA’s involvement has helped our clients solve their most challenging strategic problems and resolve their most contentious disputes.


  • 01
    AAA dispute involving the breach of a license and supply agreement between biopharmaceutical companies
    CRA was retained by the claimant in an arbitration regarding the breach of a license agreement relating to pharmaceutical manufacturing technology. In addition...
    View engagement
  • 02
    Breach of a global co-marketing deal: Swiss arbitration
    Situation: Our client, a major pharmaceutical manufacturer, had to prove damages from the wrongful termination of its global co-marketing/co-promotion rights...
    View engagement
  • 03
    AAA arbitration regarding a collaboration and license agreement
    CRA provided expert reports and testimony on behalf of the respondent in an AAA arbitration concerning the “fair market value” of rights exchanged in later...
    View engagement

Related capabilities

Subscribe to receive our latest Insights.